🔴 BreakingDrug approvalEMAMay 11
New medicine to reduce triglycerides in adults with familial chylomicronaemia syndrome
The European Medicines Agency has approved a new medicine called Redemplo (plozasiran) for adults with familial chylomicronaemia syndrome (FCS), a rare genetic condition where the body cannot properly break down certain fats in the blood. This medicine helps reduce triglycerides, which are a type of fat that builds up to dangerous levels in people with FCS. The approval means the medicine is now available for patients in the European Union.
WHY IT MATTERSAdults with FCS in the EU now have access to a new treatment option that specifically targets triglyceride reduction, potentially reducing their risk of severe pancreatitis and other complications from extremely high blood fat levels.